Charles Winter
Chief Tech/Sci/R&D Officer at JANUX THERAPEUTICS, INC.
Net worth: 3 M $ as of 2024-05-30
Charles Winter active positions
Companies | Position | Start | End |
---|---|---|---|
JANUX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-12-31 | - |
Career history of Charles Winter
Former positions of Charles Winter
Companies | Position | Start | End |
---|---|---|---|
ANAPTYSBIO, INC. | Corporate Officer/Principal | 2020-07-31 | 2021-02-28 |
SYNTHORX, INC. | Corporate Officer/Principal | 2019-12-31 | 2020-07-31 |
DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 2016-10-31 | 2018-05-31 |
JHL BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 2015-06-30 | 2016-07-31 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2011-08-31 | 2015-05-31 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 1993-12-31 | 2011-08-31 |
Training of Charles Winter
University of Wisconsin | Undergraduate Degree |
Statistics
International
United States | 8 |
Cayman Islands | 2 |
Operational
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 8 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
JANUX THERAPEUTICS, INC. | Health Technology |
ANAPTYSBIO, INC. | Health Technology |
DENALI THERAPEUTICS INC. | Health Technology |
Private companies | 3 |
---|---|
Eden Biologics, Inc.
Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
Synthorx, Inc.
Synthorx, Inc. BiotechnologyHealth Technology Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Charles Winter
- Experience